| Literature DB >> 27211287 |
Yoshio Kiku1, Yuya Nagasawa, Fuyuko Tanabe, Kazue Sugawara, Atsushi Watanabe, Eiji Hata, Tomomi Ozawa, Kei-Ichi Nakajima, Toshiro Arai, Tomohito Hayashi.
Abstract
Staphylococcus aureus (SA) is a major cause of bovine mastitis, but its pathogenic mechanism remains poorly understood. To evaluate the role of lipoteichoic acid (LTA) in the immune or inflammatory response of SA mastitis, we investigated the gene expression profile in bovine mammary epithelial cells stimulated with LTA alone or with formalin-killed SA (FKSA) using cap analysis of gene expression. Seven common differentially expressed genes related to immune or inflammatory mediators were up-regulated under both LTA and FKSA stimulations. Three of these genes encode chemokines (IL-8, CXCL6 and CCL2) functioning as chemoattractant molecules for neutrophils and macrophages. These results suggest that the initial inflammatory response of SA infection in mammary gland may be related with LTA induced chemokine genes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27211287 PMCID: PMC5059380 DOI: 10.1292/jvms.15-0706
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Top 20 up-regulated genesa) in bovine mammary epithelial cells stimulated with lipoteichoic acid
| Gene symbol | Gene name | Gene accession | Immune response | Inflammatory response | Log FC | Common with FKSAc) stimulation | |
|---|---|---|---|---|---|---|---|
| IL8 | interleukin 8, chemokine (C-X-C motif) ligand 8 (CXCL8) | NM_173925.2 | Yes | Yes | 6.1 | 3.20E-25 | Yes |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | NM_174300.2 | Yes | Yes | 4.14 | 6.10E-78 | Yes |
| MCM7 | minichromosome maintenance complex component 7 | NM_001025345.2 | 3.66 | 0.03 | |||
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | NM_173941.2 | 2.73 | 0.0089 | Yes | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | NM_001045868.1 | 1.53 | 0.0065 | |||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | NM_001045941.1 | Yes | 1.43 | 0.0089 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | NM_174006.2 | Yes | Yes | 1.37 | 3.90E-13 | Yes |
| IL1A | interleukin 1, alpha | NM_174092.1 | Yes | Yes | 1.2 | 0.0019 | Yes |
| MOV10 | Mov10 RISC complex RNA helicase | NM_001075839.1 | 1.19 | 0.017 | |||
| PRKCSH | protein kinase C substrate 80K-H | NM_176662.1 | 0.96 | 0.028 | |||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | NM_174726.1 | Yes | 0.92 | 8.80E-07 | Yes | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | NM_174445.2 | 0.88 | 0.0021 | Yes | ||
| RPS2 | ribosomal protein S2 | NM_001033613.1 | 0.86 | 0.033 | |||
| ZNF706 | zinc finger protein 706 | NM_001199073.1 | 0.8 | 0.022 | |||
| LOC504599 | histone H3.2 | NM_001166569.1 | 0.77 | 0.022 | |||
| KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 | NM_001079779.1 | 0.74 | 0.023 | |||
| ADM | adrenomedullin | NM_173888.3 | 0.72 | 0.0065 | |||
| LOC505183 | histone H2B type 1-like | XM_581429.4 | 0.66 | 0.024 | |||
| HIST1H2AC | histone cluster 1, H2ac | XM_603142.2 | 0.61 | 0.033 | |||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | NM_174267.2 | 0.61 | 0.0008 |
a) Up-regulated genes showing a value greater than 1 log FC, defined as the logarithm of the gene expression level in a sample relative to that of the non-stimulated control. b) Significance of the difference in gene expression levels between the sample and control. c) Formalin-killed Staphylococcus aureus.
Top 20 up-regulated genesa) in bovine mammary epithelial cells following stimulation with formalin-killed Staphylococcus aureus
| Gene symbol | Gene name | Gene accession | Immune response | Inflammatory response | Log FC | Common with LTAc) stimulation | |
|---|---|---|---|---|---|---|---|
| IL8 | interleukin 8,chemokine (C-X-C motif) ligand 8 (CXCL8) | NM_173925.2 | Yes | Yes | 4.92 | 1.90E-10 | Yes |
| SPP1 | secreted phosphoprotein 1 | NM_174187.2 | Yes | 3.51 | 5.90E-39 | ||
| ANKRD37 | ankyrin repeat domain 37 | NM_001075392.1 | 3.07 | 0.0089 | |||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | NM_174300.2 | Yes | Yes | 2.74 | 1.60E-24 | Yes |
| C29H11orf86 | chromosome 29 open reading frame, human C11orf86 | NM_001077090.1 | 2.7 | 0.035 | |||
| GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 | NM_175777.3 | 2.66 | 0.0035 | |||
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | NM_173941.2 | 2.57 | 0.013 | Yes | ||
| ATP6V1C1 | ATPase, H+ transporting, lysosomal 42 kDa, V1 subunit C1 | NM_176676.1 | 2.07 | 0.045 | |||
| ERAP2 | endoplasmic reticulum aminopeptidase 2 | NM_001075628.2 | Yes | 2.07 | 0.015 | ||
| CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | NM_001192294.1 | 1.65 | 0.0043 | |||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | NM_174445.2 | 1.49 | 2.20E-12 | Yes | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | NM_174267.2 | 1.11 | 4.90E-11 | |||
| CCL2 | chemokine (C-C motif) ligand 2 | NM_174006.2 | Yes | Yes | 1.07 | 0.013 | Yes |
| IL1A | interleukin 1, alpha | NM_174092.1 | Yes | Yes | 1.02 | 0.032 | Yes |
| C27H8orf4 | chromosome 27 open reading frame, human C8orf4 | NM_001035490.2 | 1.01 | 5.00E-09 | |||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | NM_174726.1 | Yes | 0.83 | 0.00019 | Yes | |
| DUSP6 | dual specificity phosphatase 6 | NM_001046195.1 | 0.78 | 8.40E-05 | |||
| MASTL | microtubule associated serine/threonine kinase-like | NM_001113765.1 | 0.71 | 0.011 | |||
| SIK1 | salt-inducible kinase 1 | XM_003581774.1 | 0.67 | 0.0024 | |||
| BCL3 | B-cell CLL/lymphoma 3 | NM_001205993.1 | Yes | 0.64 | 0.023 |
a) Up-regulated genes showing a value greater than 1 log FC, defined as the logarithm of the gene expression level in a sample relative to that of the non-stimulated control.b) Significance of the difference in gene expression levels between the sample and control. c) Lipoteichoic acid.